ExoCardio 500
iEPC-Derived Exosomes – 500 Billion Bioactive Particles
Targeting Cardiovascular, Neurological and Metabolic Conditions
CVD-500 is a cutting-edge exosome therapy developed from induced Endothelial Progenitor Cells (iEPCs). Rich in regenerative and immunomodulatory molecules, it delivers a powerful dose of 500 billion exosome particles per treatment, precisely sized between 30–200nm for optimal bioavailability and therapeutic effect.
This product is engineered under GMP standards with strict sterility assurance and quality control, including testing for endotoxin levels, purity and biological activity — ensuring maximum safety and efficacy.
Why Choose CVD-500?
Cardiovascular Regeneration
• Promotes angiogenesis (new blood vessel formation)
• Protects and strengthens cardiomyocytes (heart muscle cells)
• Improves circulation and cardiac function
Neurovascular Support
• Supports neural repair and enhances brain blood flow
• Reduces neuroinflammation, helping with recovery from
stroke or neurodegeneration
Metabolic Regulation
• Aids in improving insulin sensitivity and liver function
• Helps reduce systemic inflammation often linked to
metabolic disorders
Quality & Safety First
• Manufactured under GMP-compliant protocols
• Free from harmful contaminants
• Rigorously tested for sterility, endotoxin levels and bioactivity